没有合适的资源?快使用搜索试试~ 我知道了~
全球药物研究和开发趋势调研(英).pdf
1.该资源内容由用户上传,如若侵权请联系客服进行举报
2.虚拟产品一经售出概不退款(资源遇到问题,请及时私信上传者)
2.虚拟产品一经售出概不退款(资源遇到问题,请及时私信上传者)
版权申诉
0 下载量 170 浏览量
2022-11-16
16:04:01
上传
评论
收藏 2.5MB PDF 举报
温馨提示
![preview](https://dl-preview.csdnimg.cn/87034263/0001-ae34f4043c4a33d6dfea9cf2ef5fbd8a_thumbnail.jpeg)
![preview-icon](https://csdnimg.cn/release/downloadcmsfe/public/img/scale.ab9e0183.png)
试读
42页
全球药物研究和开发趋势调研(英).pdf
资源推荐
资源详情
资源评论
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![thumb](https://img-home.csdnimg.cn/images/20210720083646.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![thumb](https://img-home.csdnimg.cn/images/20210720083646.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![zip](https://img-home.csdnimg.cn/images/20210720083736.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![doc](https://img-home.csdnimg.cn/images/20210720083327.png)
![pdf](https://img-home.csdnimg.cn/images/20210720083512.png)
![](https://csdnimg.cn/release/download_crawler_static/87034263/bg1.jpg)
HELPING DELIVER LIFE-CHANGING THERAPIES
1
TRENDS IN PHARMACEUTICAL
RESEARCH AND DEVELOPMENT
Data Report: The State of the Drug Development Industry
Methodology & Profile 2
Executive Summary 7
Drug Development 13
Decentralized Trials 20
Outsourcing 24
Patient Recruitment 29
Appendix:
Open-Ended Responses:
Patient Recruitment 33
Screening Questions/
Demographics 39
![](https://csdnimg.cn/release/download_crawler_static/87034263/bg2.jpg)
HELPING DELIVER LIFE-CHANGING THERAPIES
22
METHODOLOGY & PROFILE
![](https://csdnimg.cn/release/download_crawler_static/87034263/bg3.jpg)
HELPING DELIVER LIFE-CHANGING THERAPIES
3
152
participants were
surveyed in April 2022
Participants were heavily screened to ensure
they met the following criteria:
Industry: Pharma, biopharma, or
biotech company
Level: Have drug development
decision-making responsibility and
be director-level or above
Role: Work in a role related to
drug development
Company: Have at least one
compound in development
Geography: US/Canada, Europe,
Asia, Australia, or Middle East/India
Survey was conducted on
behalf of PPD, part of Thermo
Fisher Scientific, by Industry
Standard Research (ISR), using
ISR’s proprietary Health Panel.
Participants were provided an
honorarium for their time.
Methodology & Profile
![](https://csdnimg.cn/release/download_crawler_static/87034263/bg4.jpg)
HELPING DELIVER LIFE-CHANGING THERAPIES
4
Statistical Differences
Statistically significant differences between segments at a 95% confidence level are
shown in callout boxes throughout the report with the data for each segment
in parentheses.
In the example above, the data from respondents from small companies is significantly
higher than that of respondents at mid-size and large companies.
Data were analyzed using statistical crosstabs to check for any statistically significant
differences across demographic segments, including:
Geography Company Size Role
US/Canada (n=75)
Europe (n=46)
Asia/Pacific (n=31)
Small: Annual R&D
Spend < $100M (n=42)
Mid: Annual revenue
$100M - $999M (n=41)
Large: Annual R&D
Spend ≥ $1B (n=69)
Director (n=95)
VP/C-Suite (n=57)
Small (57%) vs. Mid (22%)
and Large (15%)
![](https://csdnimg.cn/release/download_crawler_static/87034263/bg5.jpg)
HELPING DELIVER LIFE-CHANGING THERAPIES
5
Company Type Annual R&D Spend
Geography Job Level
Respondent Profile
RESPONDENTS WERE SURVEYED FROM:
Pharmaceutical,
biopharma,
or biotech
company, 100%
Under
$100M, 28%
$100M to
$999M, 27%
$1B to $2B,
7%
Greater
than $2B,
38%
US/
Canada,
49%
Europe,
30%
Asia, 13%
Middle
East/India, 5%
Australia, 3%
Director, 63%
Vice President,
23%
President, 3%
C-level, 11%
剩余41页未读,继续阅读
资源评论
![avatar-default](https://csdnimg.cn/release/downloadcmsfe/public/img/lazyLogo2.1882d7f4.png)
![avatar](https://profile-avatar.csdnimg.cn/default.jpg!1)
如此醉123
- 粉丝: 231
- 资源: 9万+
上传资源 快速赚钱
我的内容管理 展开
我的资源 快来上传第一个资源
我的收益
登录查看自己的收益我的积分 登录查看自己的积分
我的C币 登录后查看C币余额
我的收藏
我的下载
下载帮助
![voice](https://csdnimg.cn/release/downloadcmsfe/public/img/voice.245cc511.png)
![center-task](https://csdnimg.cn/release/downloadcmsfe/public/img/center-task.c2eda91a.png)
安全验证
文档复制为VIP权益,开通VIP直接复制
![dialog-icon](https://csdnimg.cn/release/downloadcmsfe/public/img/green-success.6a4acb44.png)